Correction
Published on 11 Nov 2022
Corrigendum: Current insights into the regulation of programmed cell death by TP53 mutation in cancer
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1071831
- 1,024 views
- Frontiers in Oncology
- Cancer Genetics
- Articles
Type at least 3 characters
1,145 articles
Articles
Original Research
Published on 11 Nov 2022
Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.941868
- 5,358 views
- 4 citations
Original Research
Published on 10 Nov 2022
Mutational patterns along different evolution paths of follicular lymphoma
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1029995
- 1,415 views
- 3 citations
Case Report
Published on 07 Nov 2022
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1030232
- 2,812 views
- 4 citations
Editorial
Published on 03 Nov 2022
Editorial: Epigenetics and molecular genetics of rare tumors
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1049140
- 1,099 views
Original Research
Published on 03 Nov 2022
The Global research of protein post-translational modifications in the cancer field: A bibliometric and visualized study
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.978464
- 3,278 views
- 2 citations
Original Research
Published on 03 Nov 2022
Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1021845
- 3,808 views
- 9 citations
Original Research
Published on 02 Nov 2022
Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1016542
- 4,070 views
- 3 citations
Original Research
Published on 01 Nov 2022
Whole exome sequencing identified a novel POT1 variant as a candidate pathogenic allele underlying a Li–Fraumeni-like family
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.963364
- 2,846 views
- 5 citations
Original Research
Published on 28 Oct 2022
Mono- and biallelic germline variants of DNA glycosylase genes in colon adenomatous polyposis families from two continents
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.870863
- 2,342 views
- 2 citations
Review
Published on 28 Oct 2022
Bladder paraganglioma, gastrointestinal stromal tumor, and SDHB germline mutation in a patient with Carney-Stratakis syndrome: A case report and literature review
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1030092
- 3,191 views
- 4 citations
Original Research
Published on 26 Oct 2022
A novel risk model construction and immune landscape analysis of gastric cancer based on cuproptosis-related long noncoding RNAs
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1015235
- 4,184 views
- 8 citations
Original Research
Published on 26 Oct 2022
Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1005812
- 2,559 views
- 11 citations
Original Research
Published on 26 Oct 2022
Clinical significance of MMP-9 overexpression in endometrial cancer: A PRISMA-compliant meta-analysis
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.925424
- 1,704 views
- 6 citations
Original Research
Published on 24 Oct 2022
Determination of a DNA repair-related gene signature with potential implications for prognosis and therapeutic response in pancreatic adenocarcinoma
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.939891
- 2,419 views
- 3 citations
Mini Review
Published on 20 Oct 2022
Alternative and aberrant splicing of human endogenous retroviruses in cancer. What about head and neck? —A mini review
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.1019085
- 2,722 views